SAN FRANCISCO, CA and VANCOUVER, BC, /CNW/ — ESSA Pharma Inc. (“ESSA”, or the “Company”) (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer,… Read More
Exciting news from VoxCell BioInnovation! We are delighted to share a significant milestone achieved by VoxCell BioInnovation – the publication of our groundbreaking paper, “Preclinical Testing Techniques: Paving the Way… Read More
VANCOUVER, BC, (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, announced that the company will present at TD Cowen’s 3rd Annual Novel Mechanisms in Neuropsychiatry Summit to… Read More
TORONTO, ON — For more than 135 years, Johnson & Johnson (the “Company”) (NYSE: JNJ) has provided health care products and solutions to people worldwide. Now, with its exclusive focus… Read More
VANCOUVER, BC, — Bold Therapeutics, a clinical-stage biopharmaceutical company developing novel metallotherapeutics, is announcing its selection by Life Sciences British Columbia (LSBC) for the 2023 ‘Company to Watch’ Honour Roll…. Read More
